JPRN-UMIN000013811招募中未知
Effect of nucleosid analog and peginterferon alfa 2a sequential therapy on patients with chronic hepatitis B - Sequential therapy with chronic hepatitis B
General Internal Medicine2 Kawasaki Medical School0 个研究点目标入组 50 人开始时间: 2014年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients receiving Chinese herb (sho-sai-ko-to) 2) Patients with history of interstitial pneumonia 3) Patients with auto immune hepatitis 4) Patients with hypersensitivity to interferon 5) Patients with hypersensitivity to biological agents 6) Patients with neutropenia (<1500/mm3), thrombocytopenia (<90000/mm3), or anemia (Hb<12g/dL) 7) Cirrhotic patients 8) Patients with history of HCC 9) Doctors consider inadequate
研究者
相似试验
招募中
4 期
Examination of the nucleoside analog-PEG-IFN alpha 2a sequential therapy for Drug Freechronic hepatitis BJPRN-UMIN000007231Division of Gastroenterology, Department of Internal Medicine,Kobe University Graduate School of Medicine100
Unknown
不适用
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisLiver FibrosisHepatitis BNCT03920605Third Affiliated Hospital, Sun Yat-Sen University100
Unknown
不适用
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosisLiver FibrosisHepatitis BNCT03919565Third Affiliated Hospital, Sun Yat-Sen University120
已完成
3 期
The effect of Combination Peg interferon –alpha to Tenofovir versus each one of the treatment modalities alone on Patients with HBeAg-negative: A randomized clinical trialIRCT20181113041635N1vice presidency for siences and technology , Iran national silences foundation60
招募中
不适用
ucleotide analog and/or peginterferon alpha-2a therapy for HBeAg-negative chronic hepatitis B.HBeAg-negative chronic hepatitis BJPRN-UMIN000010594Gunma University Graduate School of Medicine35